EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers

Ângela Marques-Magalhães iD, Sara Monteiro-Ferreira iD, Pedro Amoroso Canão, Elisabete Rios, Ângela Margarida Costa, Flávia Castro iD, Sérgia Velho, Joana Paredes iD, Fátima Carneiro iD, Maria José Oliveira, Ana Patrícia Cardoso

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ângela Marques-Magalhães und 10 weiteren Autor:innen. Beteiligte Einrichtung: i3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Colorectal Neoplasms, Extracellular Matrix, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FEDER—Fundo Europeu de Desenvolvimento Regional funds, FCT, Institute Français du Portugal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although it has been shown that the tumor extracellular matrix (ECM) may sustain the cancer stem cell (CSC) niche, its role in the modulation of CSC properties remains poorly characterized. To elucidate this, paired tumor and adjacent normal mucosa, derived from colon cancer patients’ surgical resections, were decellularized and recellularized with two distinct colon cancer cells, HT-29 or HCT-15.

Methods

The matrix impact on cancer stem cell marker expression was evaluated by flow cytometry and qRT-PCR, while transforming growth factor-β (TGF-β) secretion and matrix metalloprotease (MMP) activity were quantified by ELISA and zymography.

Results

In contrast to their paired normal counterparts, the tumor decellularized matrices enhanced HT-29 expression of the pluripotency and stemness genes NANOG (p = 0.0117), SOX2 (p = 0.0156), and OCT4 (p = 0.0312) and of the epithelial-to-mesenchymal transition (EMT)-associated transcription factor SNAI1 (p = 0.0156). Notably, no significant differences were found in the expression of SLUG or TGFB on HT-29 or of the six transcripts on HCT-15 cells. HT-29 mRNA alterations were followed by enhanced expression of the stemness-associated receptors cluster of differentiation 44 (CD44), CD133, and CD166 (p = 0.0078), the secretion of TGF-β (p = 0.0286), and MMP-2 (p = 0.0081) and MMP-9 (p = 0.0402) proteolysis. To infer the clinical relevance of these findings, we assessed cohort databases and evidenced that patients expressing higher levels of the four stemness-associated genes (NANOG/SOX2/OCT4/SNAI1) had worse overall survival. This study demonstrates that normal and tumor matrices harbor different stemness potential and suggest patient-derived decellularized matrices as an excellent three-dimensional (3D) model to unveil stemness signatures, appointing candidates for future therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsColorectal NeoplasmsExtracellular MatrixBiomarkers, TumorHumansHT29 CellsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticTransforming Growth Factor betaCell Line, TumorNanog Homeobox ProteinFemaleMaleMiddle Aged

Stichwörter der Autor:innen

cancer stem cellscolorectal cancerextracellular matrixtissue decellularization

Substanzen

Biomarkers, TumorTransforming Growth Factor betaNanog Homeobox ProteinNANOG protein, human

Autor:innen und Institutionen

  • i3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
  • ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • Champalimaud Research, Champalimaud Foundation, 1400-038 Lisbon, Portugal.
  • Centro Hospitalar Universitário São João, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
  • FMUP-Faculty of Medicine of the University of Porto, Pathology Department, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.

ORCID-Profile: Ângela Marques-Magalhães, Sara Monteiro-Ferreira, Flávia Castro, Joana Paredes, Fátima Carneiro

Förderung

  • FEDER—Fundo Europeu de Desenvolvimento Regional funds
  • FCT
  • Institute Français du Portugal
  • European Regional Development Fund

Zitieren

APA

Marques-Magalhães, Â., Monteiro-Ferreira, S., Canão, P. A., Rios, E., Costa, Â. M., Castro, F., Velho, S., Paredes, J., Carneiro, F., Oliveira, M. J., & Cardoso, A. P. (2025). Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072890

Vancouver

Marques-Magalhães Â, Monteiro-Ferreira S, Canão PA, Rios E, Costa ÂM, Castro F, et al. Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072890

BibTeX
@article{MarquesMagalhes2025,
  author = {Marques-Magalhães, Ângela and Monteiro-Ferreira, Sara and Canão, Pedro Amoroso and Rios, Elisabete and Costa, Ângela Margarida and Castro, Flávia and Velho, Sérgia and Paredes, Joana and Carneiro, Fátima and Oliveira, Maria José and Cardoso, Ana Patrícia},
  title = {Patient-Derived Colorectal Cancer Extracellular Matrices Modulate Cancer Cell Stemness Markers},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072890}
}
Kostenlos starten →